Sign inGet started

LYEL

Lyell Immunopharma, Inc.CIK 1806952 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$425.7K
17 trades · 6 insiders
Net · 90d
$-425.7K
Insiders on file
28

AI insights for LYEL PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for LYEL
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$374.0K2026-08-10 buys — 2026-08-10 sales $35.3K08-102026-08-21 buys — 2026-08-21 sales $374.0K08-212026-09-10 buys — 2026-09-10 sales $12.7K09-102026-10-12 buys — 2026-10-12 sales $3.6K10-12
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Aguirre Jarrad MattieuChief Medical Officer3$0$3.6K2026-10-12
Shook DavidChief Medical Officer6$0$37.7K2026-09-10
Lee Gary K.Chief Scientific Officer24$0$114.3K2026-08-21
Hill Stephen J.Chief Technical Ops. Officer34$0$80.4K2026-08-21
Seely LynnPresident and CEO, Director24$106.8K$592.5K2026-08-21
Bulis Veronica SanchezVP, Corporate Controller8$0$105.8K2026-08-10
Innovative Cellular Therapeutics Holdings Ltd10% Owner6$0$2742026-07-27
Bachleda MarkDirector2$0$02026-06-10
NABEL ELIZABETH GDirector6$0$02026-06-10
Klausner RichardExecutive Chairman11$94.8K$203.3K2026-06-10
Ramachandra SumantDirector4$116.0K$02026-06-10
FRIEDMAN CATHYDirector11$300.0K$02026-06-10
BRAWLEY OTIS WDirector7$20.0K$02026-06-10
RIEFLIN WILLIAM JLDirector6$0$02026-06-10
Shah SmitalChief Fin. and Bus. Officer1$0$02026-03-09
ARCH Venture Partners IX Overage, L.P.10% Owner1$12.50M$02026-03-06
BERNS PAUL L10% Owner1$12.50M$02026-03-06
Meltz Mark AGeneral Counsel2$0$02026-02-10
Newton Charles W.Chief Financial Officer20$112.0K$18.1K2025-08-21
Lang MatthewChief Business Officer6$0$02025-02-10
Bishop Hans EdgarDirector10$0$02024-06-14
NELSEN ROBERTDirector, 10% Owner10$0$02024-06-14
Albertson Tina M.Chief Medical Officer1$0$02023-02-24
Thompson RahsaanChief Legal Officer2$0$02023-02-24
Homans ElizabethChief Executive Officer2$0$02022-03-16
Turner Heather DChief General Counsel1$0$02022-03-16
ARCH Venture Fund IX, L.P.10% Owner6$0$02021-06-21
GLAXOSMITHKLINE PLC10% Owner2$0$02021-06-21

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Aguirre Jarrad MattieuChief Medical Officer S Sale2026-10-122026-10-13422$8.63 $3.6K19,857SEC↗
Aguirre Jarrad MattieuChief Medical Officer A Award deriv2026-09-102026-09-1047,500— $047,500SEC↗
Shook DavidChief Medical Officer S Sale2026-09-102026-09-10500$12.70 $6.3K20,423SEC↗
Shook DavidChief Medical Officer S Sale2026-09-102026-09-10500$12.70 $6.3K20,423SEC↗
Aguirre Jarrad MattieuChief Medical Officer A Award deriv2026-09-102026-09-1047,500— $047,500SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-08-212026-08-251,457$15.54 $22.6K16,220SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-08-212026-08-25989$15.54 $15.4K16,816SEC↗
Seely LynnPresident and CEO S Sale2026-08-212026-08-259,589$15.54 $149.0K63,899SEC↗
Seely LynnPresident and CEO, Director S Sale2026-08-212026-08-259,589$15.54 $149.0K63,899SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-08-212026-08-251,457$15.54 $22.6K16,220SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-08-212026-08-25989$15.54 $15.4K16,816SEC↗
Seely LynnPresident and CEO S Sale2026-08-102026-08-11390$14.34 $5.6K73,488SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-08-102026-08-1189$14.34 $1.3K17,805SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-08-102026-08-11131$14.34 $1.9K17,677SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2026-08-102026-08-11621$14.34 $8.9K14,799SEC↗
Seely LynnPresident and CEO, Director S Sale2026-08-102026-08-11390$14.34 $5.6K73,488SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-08-102026-08-11131$14.34 $1.9K17,677SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-08-102026-08-1189$14.34 $1.3K17,805SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2026-08-102026-08-11621$14.34 $8.9K14,799SEC↗
Innovative Cellular Therapeuti10% Owner J Other2026-07-272026-07-2738,500— $02,818,980SEC↗
Innovative Cellular Therapeuti10% Owner J Other2026-07-272026-07-2744,000— $02,774,980SEC↗
Innovative Cellular Therapeuti10% Owner S Sale2026-07-172026-07-2010$13.70 $1372,857,480SEC↗
Innovative Cellular Therapeuti10% Owner S Sale2026-07-162026-07-1710$13.73 $1372,857,490SEC↗
Innovative Cellular Therapeuti10% Owner J Other2026-06-292026-07-0176,000— $02,857,500SEC↗
Innovative Cellular Therapeuti10% Owner J Other2026-06-152026-06-1866,500— $02,933,500SEC↗
Bachleda MarkDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
BRAWLEY OTIS WDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
FRIEDMAN CATHYDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
Klausner RichardDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
NABEL ELIZABETH GDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
Ramachandra SumantDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2026-06-102026-06-129,250— $09,250SEC↗
Shook DavidChief Medical Officer S Sale2026-06-102026-06-111,977$12.64 $25.0K20,923SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2026-05-112026-06-15217$18.91 $4.1K15,420SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-05-112026-06-1589$18.92 $1.7K17,894SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-05-112026-06-15130$18.92 $2.5K17,808SEC↗
Seely LynnPresident and CEO S Sale2026-05-112026-06-15388$18.91 $7.3K73,878SEC↗
Shah SmitalChief Fin. and Bus. Officer A Award deriv2026-03-092026-03-16140,000— $0140,000SEC↗
BERNS PAUL L10% Owner P Buy2026-03-062026-03-09488,090$25.61 $12.50M1,426,528SEC↗
ARCH Venture Partners IX Overa10% Owner P Buy2026-03-062026-03-09488,090$25.61 $12.50M1,426,528SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-02-112026-02-121,671$23.39 $39.1K16,938SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-02-112026-02-121,236$23.39 $28.9K17,795SEC↗
Seely LynnPresident and CEO S Sale2026-02-112026-02-127,455$23.39 $174.4K74,266SEC↗
Shook DavidChief Medical Officer A Award deriv2026-02-102026-02-1150,000— $050,000SEC↗
Meltz Mark AGeneral Counsel A Award deriv2026-02-102026-02-1150,000— $050,000SEC↗
Seely LynnPresident and CEO A Award deriv2026-02-102026-02-11155,000— $0155,000SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2026-02-102026-02-1150,000— $050,000SEC↗
Hill Stephen J.Chief Operating Officer A Award deriv2026-02-102026-02-1165,000— $065,000SEC↗
Bulis Veronica SanchezVP, Corporate Controller A Award2026-02-102026-02-118,750— $015,891SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2026-02-102026-02-11254$23.12 $5.9K15,637SEC↗
Seely LynnPresident and CEO S Sale2026-02-102026-02-11438$23.12 $10.1K81,721SEC↗
Lee Gary K.Chief Scientific Officer S Sale2026-02-102026-02-11147$23.12 $3.4K18,609SEC↗
Hill Stephen J.Chief Operating Officer S Sale2026-02-102026-02-11109$23.12 $2.5K19,031SEC↗
Seely LynnPresident and CEO A Award2026-02-092026-02-1120,000— $082,159SEC↗
Lee Gary K.Chief Scientific Officer A Award2026-02-092026-02-114,000— $018,756SEC↗
Hill Stephen J.Chief Operating Officer A Award2026-02-092026-02-114,000— $019,140SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2025-12-302026-01-06936$32.32 $30.3K7,141SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2025-12-242026-01-061,136$38.67 $43.9K8,077SEC↗
Hill Stephen J.Chief Operating Officer S Sale2025-11-102025-11-1295$16.12 $1.5K15,750SEC↗
Lee Gary K.Chief Scientific Officer S Sale2025-11-102025-11-12138$16.16 $2.2K15,366SEC↗
Bulis Veronica SanchezVP, Corporate Controller S Sale2025-11-102025-11-12239$16.10 $3.8K9,213SEC↗
Seely LynnPresident and CEO S Sale2025-11-102025-11-12412$16.11 $6.6K67,159SEC↗
Seely LynnPresident and CEO A Award deriv2025-10-272025-10-29175,000— $0175,000SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2025-10-272025-10-2968,000— $068,000SEC↗
Hill Stephen J.Chief Operating Officer A Award deriv2025-10-272025-10-2975,000— $075,000SEC↗
Lee Gary K.Chief Scientific Officer S Sale2025-08-212025-08-221,453$10.54 $15.3K15,504SEC↗
Newton Charles W.Chief Financial Officer S Sale2025-08-212025-08-221,453$10.54 $15.3K15,306SEC↗
Hill Stephen J.Chief Operating Officer S Sale2025-08-212025-08-221,004$10.54 $10.6K15,845SEC↗
Seely LynnPresident and CEO S Sale2025-08-212025-08-227,257$10.54 $76.5K67,571SEC↗
Lee Gary K.Chief Scientific Officer A Award2025-08-202025-08-228,000— $016,957SEC↗
Newton Charles W.Chief Financial Officer A Award2025-08-202025-08-228,000— $016,759SEC↗
Hill Stephen J.Chief Operating Officer A Award2025-08-202025-08-228,000— $016,849SEC↗
Seely LynnPresident and CEO A Award2025-08-202025-08-2240,000— $074,828SEC↗
Newton Charles W.Chief Financial Officer S Sale2025-08-122025-08-13136$10.34 $1.4K8,759SEC↗
Lee Gary K.Chief Scientific Officer S Sale2025-08-122025-08-13136$10.34 $1.4K8,957SEC↗
Hill Stephen J.Chief Operating Officer S Sale2025-08-122025-08-1394$10.34 $9728,849SEC↗
Seely LynnPresident and CEO S Sale2025-08-122025-08-13406$10.34 $4.2K34,828SEC↗
Newton Charles W.Chief Financial Officer S Sale2025-08-112025-08-13131$10.53 $1.4K8,895SEC↗
Lee Gary K.Chief Scientific Officer S Sale2025-08-112025-08-13131$10.53 $1.4K9,093SEC↗
Hill Stephen J.Chief Operating Officer S Sale2025-08-112025-08-1391$10.53 $9588,943SEC↗
Seely LynnPresident and CEO S Sale2025-08-112025-08-13391$10.53 $4.1K35,234SEC↗
Shook DavidChief Medical Officer A Award deriv2025-06-092025-06-1143,750— $043,750SEC↗
Meltz Mark AGeneral Counsel A Award deriv2025-06-092025-06-11100,000— $0100,000SEC↗
Bachleda MarkDirector A Award deriv2025-06-092025-06-1113,000— $013,000SEC↗
Shook DavidChief Medical Officer A Award2025-06-092025-06-1121,900— $021,900SEC↗
Ramachandra SumantDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
NABEL ELIZABETH GDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
BRAWLEY OTIS WDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
FRIEDMAN CATHYDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
Klausner RichardDirector A Award deriv2025-05-152025-05-19130,000— $0130,000SEC↗
BRAWLEY OTIS WDirector P Buy2025-03-312025-04-0235,640$0.56 $20.0K35,640SEC↗
Ramachandra SumantDirector P Buy2025-03-212025-03-25200,000$0.58 $116.0K200,000SEC↗
Newton Charles W.Chief Financial Officer P Buy2025-03-172025-03-18200,000$0.56 $112.0K200,000SEC↗
Seely LynnPresident and CEO P Buy2025-03-142025-03-18175,000$0.61 $106.8K712,500SEC↗
Klausner RichardDirector P Buy2025-03-142025-03-18158,000$0.60 $94.8K843,365SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2025-02-102025-02-26450,000— $0450,000SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2025-02-102025-02-2656,250— $056,250SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2025-02-102025-02-2656,250— $056,250SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2025-02-102025-02-26450,000— $0450,000SEC↗
Hill Stephen J.Chief Operating Officer A Award deriv2025-02-102025-02-26450,000— $0450,000SEC↗
Hill Stephen J.Chief Operating Officer A Award deriv2025-02-102025-02-2656,250— $056,250SEC↗
Seely LynnPresident and CEO A Award deriv2025-02-102025-02-26168,750— $0168,750SEC↗
Seely LynnPresident and CEO A Award deriv2025-02-102025-02-261,350,000— $01,350,000SEC↗
Lang MatthewChief Business Officer A Award deriv2025-02-102025-02-2656,250— $056,250SEC↗
Lang MatthewChief Business Officer A Award deriv2025-02-102025-02-26450,000— $0450,000SEC↗
Lee Gary K.Chief Scientific Officer A Award2025-02-102025-02-26112,500— $0176,696SEC↗
Newton Charles W.Chief Financial Officer A Award2025-02-102025-02-26112,500— $0172,725SEC↗
Hill Stephen J.Chief Operating Officer A Award2025-02-102025-02-26112,500— $0172,899SEC↗
Seely LynnPresident and CEO A Award2025-02-102025-02-26337,500— $0537,500SEC↗
Lang MatthewChief Business Officer A Award2025-02-102025-02-26112,500— $0162,500SEC↗
Ramachandra SumantDirector A Award deriv2024-10-312024-11-01260,000— $0260,000SEC↗
FRIEDMAN CATHYDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
BRAWLEY OTIS WDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
NABEL ELIZABETH GDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
Klausner RichardDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
Bishop Hans EdgarDirector A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
NELSEN ROBERTDirector, 10% Owner A Award deriv2024-06-142024-06-17130,000— $0130,000SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2024-02-092024-02-13400,000— $0400,000SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2024-02-092024-02-13400,000— $0400,000SEC↗
Hill Stephen J.Chief Operating Officer A Award deriv2024-02-092024-02-13400,000— $0400,000SEC↗
Lang MatthewChief Business Officer A Award deriv2024-02-092024-02-13500,000— $0500,000SEC↗
Seely LynnPresident and CEO A Award2024-02-092024-02-13200,000— $0200,000SEC↗
Newton Charles W.Chief Financial Officer A Award2024-02-092024-02-1340,000— $048,729SEC↗
Lee Gary K.Chief Scientific Officer A Award2024-02-092024-02-1340,000— $052,700SEC↗
Hill Stephen J.Chief Operating Officer A Award2024-02-092024-02-1340,000— $048,928SEC↗
Lang MatthewChief Business Officer A Award2024-02-092024-02-1350,000— $050,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-20450,000— $0450,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-20100,000— $0100,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-20100,000— $00SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-2085,000— $085,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-2085,000— $00SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-20700,000— $0700,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-20700,000— $00SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-20500,000— $0500,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-20500,000— $00SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-11-162023-11-20165,000— $0165,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-20165,000— $00SEC↗
Hill Stephen J.Chief Technical Ops. Officer D To issuer deriv2023-11-162023-11-20450,000— $00SEC↗
Seely LynnPresident and CEO A Award deriv2023-11-162023-11-207,500,000— $07,500,000SEC↗
Seely LynnPresident and CEO D To issuer deriv2023-11-162023-11-207,500,000— $00SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2023-11-162023-11-20800,000— $0800,000SEC↗
Lee Gary K.Chief Scientific Officer D To issuer deriv2023-11-162023-11-20800,000— $00SEC↗
Newton Charles W.Chief Financial Officer D To issuer deriv2023-11-162023-11-20516,000— $00SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2023-11-162023-11-20500,000— $0500,000SEC↗
Newton Charles W.Chief Financial Officer D To issuer deriv2023-11-162023-11-20500,000— $00SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2023-11-162023-11-20516,000— $0516,000SEC↗
Newton Charles W.Chief Financial Officer D To issuer deriv2023-11-162023-11-20190,000— $00SEC↗
Newton Charles W.Chief Financial Officer D To issuer deriv2023-11-162023-11-203,612,000— $00SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2023-11-162023-11-203,612,000— $03,612,000SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2023-11-162023-11-20190,000— $0190,000SEC↗
Bishop Hans EdgarDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
BRAWLEY OTIS WDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
NABEL ELIZABETH GDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
NELSEN ROBERTDirector, 10% Owner A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
FRIEDMAN CATHYDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
Klausner RichardDirector A Award deriv2023-09-082023-09-0855,000— $055,000SEC↗
Klausner RichardDirector S Sale2023-08-152023-08-1758,020$2.28 $132.3K930,880SEC↗
Lang MatthewChief Business Officer A Award deriv2023-08-102023-08-112,250,000— $02,250,000SEC↗
Bishop Hans EdgarDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
BRAWLEY OTIS WDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
FRIEDMAN CATHYDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
Klausner RichardDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
NABEL ELIZABETH GDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
NELSEN ROBERTDirector, 10% Owner A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2023-06-162023-06-2065,000— $065,000SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2023-02-242023-02-28700,000— $0700,000SEC↗
Thompson RahsaanChief Legal Officer A Award deriv2023-02-242023-02-28245,000— $0245,000SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2023-02-242023-02-28600,000— $0600,000SEC↗
Albertson Tina M.Chief Medical Officer A Award deriv2023-02-242023-02-28700,000— $0700,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2023-02-242023-02-28900,000— $0900,000SEC↗
Seely LynnPresident and CEO A Award deriv2022-12-152022-12-197,500,000— $07,500,000SEC↗
Thompson RahsaanChief Legal Officer A Award deriv2022-10-102022-10-12715,000— $0715,000SEC↗
Klausner RichardDirector S Sale2022-09-232022-09-2711,100$6.40 $71.0K988,900SEC↗
Bishop Hans EdgarDirector M Exercise deriv2022-09-082022-09-09145,380— $024,230SEC↗
Bishop Hans EdgarDirector M Exercise2022-09-082022-09-09145,380$0.10 $14.5K4,685,614SEC↗
Klausner RichardDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
FRIEDMAN CATHYDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
Bishop Hans EdgarDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
BRAWLEY OTIS WDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
NABEL ELIZABETH GDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
Seely LynnDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
NELSEN ROBERTDirector, 10% Owner A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2022-06-082022-06-1065,000— $065,000SEC↗
Hill Stephen J.Chief Technical Ops. Officer A Award deriv2022-03-162022-03-18700,000— $0700,000SEC↗
Homans ElizabethChief Executive Officer A Award deriv2022-03-162022-03-181,479,500— $01,479,500SEC↗
Newton Charles W.Chief Financial Officer A Award deriv2022-03-162022-03-18500,000— $0500,000SEC↗
Turner Heather DChief General Counsel A Award deriv2022-03-162022-03-18300,000— $0300,000SEC↗
Bishop Hans EdgarDirector M Exercise deriv2022-02-232022-02-25993,428— $0169,610SEC↗
Bishop Hans EdgarDirector M Exercise2022-02-232022-02-25993,428$0.10 $99.3K4,540,234SEC↗
Lee Gary K.Chief Scientific Officer A Award deriv2022-02-112022-02-14800,000— $0800,000SEC↗
FRIEDMAN CATHYDirector J Other2021-12-142021-12-14218,722— $0236,370SEC↗
FRIEDMAN CATHYDirector J Other2021-12-142021-12-143,765,842— $00SEC↗
Homans ElizabethChief Executive Officer A Award deriv2021-09-132021-09-141,370,469— $01,370,469SEC↗
FRIEDMAN CATHYDirector C Conversion deriv2021-06-212021-06-233,765,842— $00SEC↗
Bishop Hans EdgarDirector C Conversion deriv2021-06-212021-06-23546,806— $00SEC↗
Klausner RichardExecutive Chairman C Conversion deriv2021-06-212021-06-233,765,842— $00SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion deriv2021-06-212021-06-23435,142— $00SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion deriv2021-06-212021-06-2317,771,216— $00SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion deriv2021-06-212021-06-2317,771,216— $00SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion deriv2021-06-212021-06-23435,142— $00SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion deriv2021-06-212021-06-23435,142— $00SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion deriv2021-06-212021-06-23435,142— $00SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion deriv2021-06-212021-06-2317,771,216— $00SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion deriv2021-06-212021-06-2317,771,216— $00SEC↗
GLAXOSMITHKLINE PLC10% Owner C Conversion deriv2021-06-212021-06-2330,253,189— $00SEC↗
FRIEDMAN CATHYDirector C Conversion2021-06-212021-06-233,765,842— $03,765,842SEC↗
FRIEDMAN CATHYDirector P Buy2021-06-212021-06-2317,648$17.00 $300.0K17,648SEC↗
Bishop Hans EdgarDirector C Conversion2021-06-212021-06-23546,806— $03,546,806SEC↗
Klausner RichardExecutive Chairman C Conversion2021-06-212021-06-233,765,842— $03,765,842SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion2021-06-212021-06-2318,206,358— $018,206,358SEC↗
NELSEN ROBERTDirector, 10% Owner C Conversion2021-06-212021-06-2318,206,358— $018,206,358SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion2021-06-212021-06-2318,206,358— $018,206,358SEC↗
ARCH Venture Fund IX, L.P.10% Owner C Conversion2021-06-212021-06-2318,206,358— $018,206,358SEC↗
GLAXOSMITHKLINE PLC10% Owner C Conversion2021-06-212021-06-2330,253,189— $030,253,189SEC↗